Log in
  • PO Box 450 Mawson ACT, 2607 Australia

  • 02 6260 4022

Tech Alert: TGA Scheduling Interim Decision Wild Cherry Bark – amygdalin and hydrocyanic acid

06 Oct 2023 9:29 AM | Anonymous member (Administrator)

The TGA has published the Scheduling interim decision on amygdalin and hydrocyanic acid, and a public consultation on the interim decision is now open, closing 2 November 2023

After considering the submissions from 36 entities, including CMA (10 submissions were opposed to the proposal) and advice of the joint Advisory Committee on Chemicals and Medicines Scheduling (ACCS- ACMS), the Delegate of the Secretary of the Department of Health and Aged Care has made an interim decision to not amend the current Poisons Standard in relation to amygdalin  and HCN.

Members are encouraged to read today’s technical alert for more information and details, including a summary of the Delegate’s reasons, relevant scheduling history, and how to respond to the interim decision consultation.

Copyright © 2019 Complementary Medicines Australia. All rights reserved.

Powered by Wild Apricot Membership Software